These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8958802)

  • 1. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
    Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
    J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are there differences between ex adenoma and de novo colorectal carcinomas?].
    Mueller J; Mueller E; Keller G; Bethke B; Stolte M; Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():139-47. PubMed ID: 10714204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
    Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
    Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin, beta-catenin and stromelysin-3 expression in de novo carcinoma of the colorectum.
    Włodarczyk J; Stolte M; Mueller J
    Pol J Pathol; 2001; 52(3):119-24. PubMed ID: 11769398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
    Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
    J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of protein p53 in the adenoma-colorectal carcinoma sequence].
    Gafà R; Lanza G
    Pathologica; 1998 Aug; 90(4):351-6. PubMed ID: 9793394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia.
    Kaklamanis L; Savage A; Mortensen N; Tsiotos P; Doussis-Anagnostopoulou I; Biddolph S; Whitehouse R; Harris AL; Gatter KC
    J Pathol; 1996 May; 179(1):10-4. PubMed ID: 8691332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis.
    Mikami T; Yanagisawa N; Baba H; Koike M; Okayasu I
    Cancer; 1999 Jan; 85(2):318-25. PubMed ID: 10023698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and bcl-2 protein expression in rectosigmoid adenomas.
    Papatheodoridis GV; Kapranos N; Tzouvala M; Triantafyllou K; Elemenoglou I; Karamanolis DG
    Am J Gastroenterol; 1998 Jul; 93(7):1136-40. PubMed ID: 9672345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
    Hornick JL; Farraye FA; Odze RD
    Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas.
    Agui T; McConkey DJ; Tanigawa N
    Anticancer Res; 2002; 22(3):1769-76. PubMed ID: 12168867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon.
    Flohil CC; Janssen PA; Bosman FT
    J Pathol; 1996 Apr; 178(4):393-7. PubMed ID: 8691316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different proliferative patterns characterize different preinvasive breast lesions.
    Viacava P; Naccarato AG; Bevilacqua G
    J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
    Shiomori K; Shimada S; Marutsuka T; Hatayama I; Ogawa M
    Int J Oncol; 2003 Jan; 22(1):65-74. PubMed ID: 12469186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of p53, c-erbB2, CEA proteins in colorectal adenoma and carcinoma].
    Shu M; Liu S; Yu P
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):129-32. PubMed ID: 10681823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
    Kim YS; Lim SD; Lee JK; Kim SE; Ryu SH; Lee JW; Moon JS
    Korean J Gastroenterol; 2006 May; 47(5):350-6. PubMed ID: 16714876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
    Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
    Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death in colorectal carcinogenesis.
    Valentini AM; Caruso ML; Armentano R; Pirrelli M; Rizzi E; Lapenna F; Renna L
    Anticancer Res; 1999; 19(4B):3019-24. PubMed ID: 10652586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.